コンパニオン診断の世界市場:免疫組織化学、ポリメラーゼ連鎖反応[PCR]、次世代シーケンシング[NGS]、in situハイブリダイゼーション...市場調査レポートについてご紹介

【英文タイトル】Companion Diagnostics Market by Technology Type (Immunohistochemistry, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], In Situ Hybridization, and Others), and Indication (Oncology, Neurology, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. Key findings

2.2.1. Top investment pockets
2.2.2. Top impacting factors

2.3. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key forces shaping companion diagnostics industry/market

3.2.1. Moderate power of suppliers
3.2.2. High threat of new entrants
3.2.3. Low threat of substitution
3.2.4. Moderate competitive rivalry
3.2.5. Moderate power of buyers

3.3. Parent/ peer market overview
3.5. Market evolution/industry roadmap
3.6. Government regulations for companion diagnostics
3.7. Market dynamics

3.7.1. Drivers

3.7.1.1. Increased popularity of personalized medicine
3.7.1.2. Increase in cases of adverse drug reactions (ADRs)
3.7.1.3. Surge in healthcare expenditure worldwide
3.7.1.4. Technological advancements in diagnostic techniques

3.7.2. Restraints

3.7.2.1. Unfavorable reimbursement policies in some countries

3.7.3. Opportunities

3.7.3.1. Growth opportunities in emerging markets
3.7.3.2. Increase in incidence of cancer across the globe

3.7.4. Impact analysis

CHAPTER 4: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY

4.1. Overview

4.1.1. Market size and forecast

4.2. Immunohistochemistry

4.2.1. Market size and forecast, by region
4.2.2. Market analysis, by country

4.3. Polymerase chain reaction (PCR)

4.3.1. Market size and forecast, by region
4.3.2. Market analysis, by country

4.4. Next generation sequencing (NGS)

4.4.1. Market size and forecast, by region
4.4.2. Market analysis, by country

4.5. In situ hybridization

4.5.1. Market size and forecast, by region
4.5.2. Market analysis, by country

4.6. Others

4.6.1. Market size and forecast, by region
4.6.2. Market analysis, by country

CHAPTER 5: COMPANION DIAGNOSTICS MARKET, BY INDICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Oncology

5.2.1. Key market trends and opportunities
5.2.2. Market size and forecast, by type

5.2.2.1. Lung cancer

5.2.2.1.1. Market size and forecast

5.2.2.2. Colorectal cancer

5.2.2.2.1. Market size and forecast

5.2.2.3. Breast cancer

5.2.2.3.1. Market size and forecast

5.2.2.4. Blood cancer

5.2.2.4.1. Market size and forecast

5.2.2.5. Others

5.2.2.5.1. Market size and forecast

5.2.3. Market size and forecast
5.2.4. Market analysis, by country

5.3. Neurology

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Others

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

CHAPTER 6: COMPANION DIAGNOSTICS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. companion diagnostics market, by technology
6.2.2.1.2. U.S. companion diagnostics market, by indication

6.2.2.2. Canada

6.2.2.2.1. Canada companion diagnostics market, by technology
6.2.2.2.2. Canada companion diagnostics market, by indication

6.2.2.3. Mexico

6.2.2.3.1. Mexico companion diagnostics market, by technology
6.2.2.3.2. Mexico companion diagnostics market, by indication

6.2.3. North America market size and forecast, by technology
6.2.4. North America Market size and forecast, by indication

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Germany companion diagnostics market, by technology
6.3.2.1.2. Germany companion diagnostics market, by indication

6.3.2.2. France

6.3.2.2.1. France companion diagnostics market, by technology
6.3.2.2.2. France companion diagnostics market, by indication

6.3.2.3. UK

6.3.2.3.1. UK companion diagnostics market, by technology
6.3.2.3.2. UK companion diagnostics market, by indication

6.3.2.4. Rest of Europe

6.3.2.4.1. Rest of Europe companion diagnostics market, by technology
6.3.2.4.2. Rest of Europe companion diagnostics market, by indication

6.3.3. Europe market size and forecast, by technology
6.3.4. Europe Market size and forecast, by indication

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country

6.4.2.1. Japan

6.4.2.1.1. Japan companion diagnostics market, by technology
6.4.2.1.2. Japan companion diagnostics market, by indication

6.4.2.2. China

6.4.2.2.1. China companion diagnostics market, by technology
6.4.2.2.2. China companion diagnostics market, by indication

6.4.2.3. Australia

6.4.2.3.1. Australia companion diagnostics market, by technology
6.4.2.3.2. Australia companion diagnostics market, by indication

6.4.2.4. Rest of Asia-Pacific

6.4.2.4.1. Rest of Asia-Pacific companion diagnostics market, by technology
6.4.2.4.2. Rest of Asia-Pacific companion diagnostics market, by indication

6.4.3. Asia-Pacific market size and forecast, by technology
6.4.4. Asia-Pacific Market size and forecast, by indication

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil companion diagnostics market, by technology
6.5.2.1.2. Brazil companion diagnostics market, by indication

6.5.2.2. South Africa

6.5.2.2.1. South Africa companion diagnostics market, by technology
6.5.2.2.2. South Africa companion diagnostics market, by indication

6.5.2.3. Rest of LAMEA

6.5.2.3.1. Rest of LAMEA companion diagnostics market, by technology
6.5.2.3.2. Rest of LAMEA companion diagnostics market, by indication

6.5.3. LAMEA market size and forecast, by technology
6.5.4. LAMEA Market size and forecast, by indication

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction

7.1.1. Market player positioning, 2018

7.2. Top winning strategies
7.3. Competitive dashboard
7.4. Competitive heatmap

CHAPTER 8: COMPANY PROFILES

8.1. Abbott Laboratories Molecular, Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments

8.2. Agilent (Dako Denmark A/S)

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments

8.3. ARUP Laboratories, Inc.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Service portfolio

8.4. BioMerieux

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance

8.5. Danaher Corporation (Leica Microsystems)

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance

8.6. Foundation Medicine, Inc.

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Service portfolio
8.6.5. Key strategic moves and developments

8.7. Myriad Genetics, Inc.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments

8.8. Roche (Ventana Medical Systems, Inc)

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments

8.9. Thermo Fisher Scientific (Life Technologies Corporation)

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments

8.10. QIAGEN N.V.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments


【レポート販売概要】

■ タイトル:コンパニオン診断の世界市場:免疫組織化学、ポリメラーゼ連鎖反応[PCR]、次世代シーケンシング[NGS]、in situハイブリダイゼーション
■ 英文:Companion Diagnostics Market by Technology Type (Immunohistochemistry, Polymerase Chain Reaction [PCR], Next Generation Sequencing [NGS], In Situ Hybridization, and Others), and Indication (Oncology, Neurology, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日:2019年7月
■ 調査会社:Allied Market Research
■ 商品コード:AMR9NV073
■ 調査対象地域:グローバル
  • オフィス文具及び備品B2Bの世界市場予測・分析2020-2024
    Global Office Stationery and Supplies B2B Market: About this market Technavio’s office stationery and supplies B2B market analysis considers sales from both offline and online distribution channels. Our study also finds the sales of office stationery and supplies B2B in APAC, Europe, MEA, North America, and South America. In 2019, the offline segment had a significant market share, and this trend …
  • OTC薬(一般用医薬品)の世界市場2016-2020
    About OTC Drugs OTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation, weight problems, gastrointestinal problems, and tooth decay. …
  • 乗用車用モーターオイル(PCMO)の世界市場
    About passenger car motor oil PCMO refers to motor oils for gasoline and diesel engines used in passenger vehicles. It reduces friction and wear and tear of the moving engine's crankshaft, connecting rods, bearings, and pistons. It also serves as an effective coolant. It inhibits the formation of deposits and prevents rust and corrosion. The market figures in the report include different viscosity …
  • Iclusig (Chronic Myeloid Leukemia):市場予測と分析(~2022)
    Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is a rare myeloproliferative blood cancer that is characterized by the presence of the BCR-ABL fusion protein. The stage of CML is classified …
  • 神経障害性疼痛:製薬企業動向
    PharmaPoint: Neuropathic Pain - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Neuropathic Pain - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Neuropathic Pain Market. The report identifies and analyses the key companies shaping and driving the global N …
  • シンガポールのデータセンター市場
    About data center A data center is a centralized facility for data computing, processing, and storage purposes. It includes high-performance servers, networking equipment, storage arrays, and supporting services such as powering and cooling solutions. Data centers are established by enterprises dealing in cloud-based service offerings. There are also many enterprises that are involved in the const …
  • 籾殻灰の世界市場予測(~2020)
    The global rice husk ash market is estimated to reach USD 2.42 Billion by 2020, at a CAGR of 5.15% between 2015 and 2020. Factors, such as growth of various end user industries and increase in the demand for light weight construction material from the building & construction industry are expected to drive the global rice husk ash market during the forecast period, from 2015 to 2020. The building & …
  • 人型ロボットの世界市場予測(~2023年)
    The humanoid robot market is expected to be valued at USD 320.3 Million in 2017 and is estimated to reach USD 3,962.5 Million by 2023, at a CAGR of 52.1% between 2017 and 2023. The humanoid robot market is mainly driven by factors such as the introduction of advanced features in humanoid robots, the increasing use of humanoids as educational robots, and growing demand from the retail industry for …
  • PA Resources AB:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013
    PA Resources AB Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary PA Resources AB Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key ope …
  • 炭素繊維プリプレグの世界市場
    The global carbon fiber prepreg market was valued at $2,633.0 million in 2014 and is estimated to reach $4,640.2 million by 2019, at a CAGR of 11.9% during the period under consideration. In this report, the global carbon fiber prepreg market has been broadly classified on the basis of application and geography. The application segment is divided into aerospace & defense, wind, sporting goods, and …
  • 世界の予測分析市場(企業IT):Global Predictive Analytics Market 2014-2018
    TechNavio's analysts forecast the Global Predictive Analytics market to grow at a CAGR of 30.19 percent over the period 2014-2018. One of the key factors contributing to this market growth is the increasing need of enterprises to remain competitive in the market. The Global Predictive Analytics market has also been witnessing the emergence of cloud-based predictive analytics. However, the lack of …
  • ケラチンの世界市場:アルファケラチン、ベータケラチン
    Global Keratin Market: About this market Keratin is extensively used as an ingredient in hair care products and medical products. Technavio’s keratin market analysis considers sales from both the segments, including beta-keratin and alpha-keratin. Our analysis also considers the sales of keratin in APAC, Europe, North America, South America, and MEA. In 2018, the alpha-keratin segment had a signif …
  • 転移性腎細胞癌:グローバル臨床試験レビュー(2014年上半期)
    Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Metastatic Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Metastatic Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Renal Cell Carcinoma. It includes …
  • 自動車用OEM高級オーディオの世界市場2019-2023
    About this market The global luxury vehicle market is witnessing growth in popularity and their demand year-on-year, which has accelerated the sales volume of premium or luxury vehicles. Luxury vehicles find a high penetration rate of advanced comfort and convenience functionalities, which also increases their value proposition. The growth in volume sales of vehicles from such luxury automakers is …
  • 軟質磁性材料の世界市場:技術、材料、デバイス、開発、産業構造
    Magnets are important and highly sophisticated engineering materials that play a fundamental role in many of the electrical and electronic systems that serve modern society. Magnets might be divided into two classes – permanent and soft magnetic materials. Permanent magnetic materials are those which are constantly magnetized, while soft magnetic materials exhibit magnetic properties only when sub …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。